文献速递疼痛医学

背根神经节神经元中磷酸化NEK2依赖的表观遗传通路介导紫杉醇诱导的神经病理性疼痛

Phosphate NIMA-Related Kinase 2-Dependent Epigenetic Pathways in Dorsal Root Ganglion Neurons Mediates Paclitaxel-Induced Neuropathic Pain.
PubMed 文献 · Anesth Analg · 2023-02-08

该研究在紫杉醇诱导神经病理性疼痛的成年雄性Sprague-Dawley大鼠模型中,发现背根神经节神经元内pRSK2/pNEK2/JMJD3/H3K27me3/TRPV1信号通路被激活,通过表观遗传去抑制Trpv1基因表达介导痛觉过敏;鞘内注射相应抑制剂或siRNA可逆转神经病理性痛觉过敏并恢复Trpv1基因沉默。

要点

  • 紫杉醇增加DRG神经元NEK2磷酸化并诱导显著神经病理性痛觉过敏。
  • pNEK2通过JMJD3降低Trpv1基因H3K27me3并增强TRPV1表达。
  • 鞘内注射RSK2、NEK2、JMJD3或TRPV1拮抗剂可逆转痛觉过敏。

核心结论

  • DRG神经元中pRSK2/JMJD3/H3K27me3/TRPV1信号通路是紫杉醇诱导神经病理性疼痛的关键调节通路。

研究设计与样本

  • 成年雄性Sprague-Dawley大鼠腹腔注射紫杉醇诱导神经病理性疼痛,采用生化分析检测DRG蛋白表达,von Frey和热板试验评估痛觉行为。

主要发现

  • 紫杉醇增加DRG神经元中NEK2的磷酸化并诱导显著神经病理性痛觉过敏。
  • pNEK2增加JMJD3蛋白,催化Trpv1基因处抑制性组蛋白标记H3K27me3去甲基化,增强DRG神经元TRPV1表达。
  • pNEK2依赖的紫杉醇反应程序受p90核糖体S6激酶2(RSK2)磷酸化增强调控。
  • 鞘内注射kaempferol、NCL 00017509、NEK2靶向siRNA、GSK-J4或capsazepine可逆转神经病理性痛觉过敏并恢复Trpv1基因沉默。

临床怎么用

  • 靶向DRG神经元pRSK2/pNEK2/JMJD3/H3K27me3/TRPV1通路可能为紫杉醇诱导神经病理性疼痛提供治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The microtubule-stabilizing drug paclitaxel (PTX) is an important chemotherapeutic agent for cancer treatment and causes peripheral neuropathy as a common side effect that substantially impacts the functional status and quality of life of patients. The mechanistic role for NIMA-related kinase 2 (NEK2) in the progression of PTX-induced neuropathic pain has not been established. METHODS: Adult male Sprague-Dawley rats intraperitoneally received PTX to induce neuropathic pain. The protein expression levels in the dorsal root ganglion (DRG) of animals were measured by biochemical analyses. Nociceptive behaviors were evaluated by von Frey tests and hot plate tests. RESULTS: PTX increased phosphorylation of the important microtubule dynamics regulator NEK2 in DRG neurons and induced profound neuropathic allodynia. PTX-activated phosphorylated NEK2 (pNEK2) increased jumonji domain-containing 3 (JMJD3) protein, a histone demethylase protein, to specifically catalyze the demethylation of the repressive histone mark H3 lysine 27 trimethylation (H3K27me3) at the Trpv1 gene, thereby enhancing transient receptor potential vanilloid subtype-1 (TRPV1) expression in DRG neurons. Moreover, the pNEK2-dependent PTX response program is regulated by enhancing p90 ribosomal S6 kinase 2 (RSK2) phosphorylation. Conversely, intrathecal injections of kaempferol (a selective RSK2 activation antagonist), NCL 00017509 (a selective NEK2 inhibitor), NEK2-targeted siRNA, GSK-J4 (a selective JMJD3 inhibitor), or capsazepine (an antagonist of TRPV1 receptor) into PTX-treated rats reversed neuropathic allodynia and restored silencing of the Trpv1 gene, suggesting the hierarchy and interaction among phosphorylated RSK2 (pRSK2), pNEK2, JMJD3, H3K27me3, and TRPV1 in the DRG neurons in PTX-induced neuropathic pain. CONCLUSIONS: pRSK2/JMJD3/H3K27me3/TRPV1 signaling in the DRG neurons plays as a key regulator for PTX therapeutic approaches.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Hsieh MC, Lai CY, Cho WL, et al. Phosphate NIMA-Related Kinase 2-Dependent Epigenetic Pathways in Dorsal Root Ganglion Neurons Mediates Paclitaxel-Induced Neuropathic Pain. Anesth Analg. 2023. PMID: 36753440. doi:10.1213/ANE.0000000000006397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。